Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Onsemi and Synaptics revise merger deal, reducing value by $1.3 billion

Onsemi and Synaptics cut the price of their merger by about $1.3 billion in a revised all-cash deal announced Oct. 1, 2026.

Under the amended agreement, Onsemi will pay $123 per share in cash for Synaptics, valuing the company at about $5.7 billion. The earlier agreement, signed June 25, had valued the transaction at about $7 billion. The new terms reduce the total deal value by roughly 19%.

Onsemi said the revised structure is expected to be immediately accretive to its non-GAAP earnings per share at closing. In the earlier announcement, the company had not said the deal would be immediately accretive. The company also said it has identified additional value beyond the previously announced $200 million in annual run-rate synergies, citing revenue synergies and insourcing of part of Synaptics’ production. Those extra benefits are expected after the first 18 months following close.

Synaptics’ board unanimously approved the amended deal after reviewing it with financial and legal advisers. The company said the all-cash structure gives shareholders value certainty at a meaningful premium to the current value.

The transaction is still expected to close by mid-2027. It will be financed with cash on hand and committed debt financing, and Onsemi said it has fully committed debt financing from Morgan Stanley. Today the company's shares have moved 1.21% to a price of $76.87. For the full picture, make sure to review ON SEMICONDUCTOR CORP's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS